Oncology in Clinical Practice

VM Media sp. z o.o. VM Group sp.k.

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in
Follow this journal
PrintDownload PDF

About the journal

Oncology in Clinical Practice is an open-access journal published by VM Media sp. z o.o. VM Group sp.k. in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
VM Media sp. z o.o. VM Group sp.k.
ISSN
1734-3542 · 1734-6460
Country
Poland
Languages
english
Access
Open access
Articles in DOAJ
0
Declared review time
15 weeks
Declared peer-review model
double_blind
Official website
https://journals.viamedica.pl/oncology_in_clinical_practice/index

Index listings

  • DOAJ · 2016-02-03
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Dormant — no works recorded since 2015
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

49

Last recorded publication year

2015

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy6
Last DOAJ review date
2025-09-22
Added to DOAJ
2016-02-03
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Editorial board
Official page ↗
Peer-review policy
View policy
Identity & continuity2
Continued by
2450-6478, 2450-1654
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • PI3K/AKT/mTOR signaling in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology
  • Chronic Lymphocytic Leukemia Research
  • HER2/EGFR in Cancer Research
  • Lung Cancer Treatments and Mutations
  • HER2/EGFR in Cancer Research
Show all subjects (50)
  • Cancer Treatment and Pharmacology
  • Lung Cancer Treatments and Mutations
  • Neuroendocrine Tumor Research Advances
  • Cancer Diagnosis and Treatment
  • Multiple and Secondary Primary Cancers
  • Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Monoclonal and Polyclonal Antibodies Research
  • Genetic factors in colorectal cancer
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Management of metastatic bone disease
  • Multiple and Secondary Primary Cancers
  • Management of metastatic bone disease
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Genetic factors in colorectal cancer
  • Renal Diseases and Glomerulopathies
  • Monoclonal and Polyclonal Antibodies Research
  • Renal Diseases and Glomerulopathies
  • Chemotherapy-related skin toxicity
  • Fungal Plant Pathogen Control
  • Management and Organizational Practices
  • Toxin Mechanisms and Immunotoxins
  • Immunodeficiency and Autoimmune Disorders
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lymphoma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Polyomavirus and related diseases
  • Chemotherapy-related skin toxicity
  • Metastasis and carcinoma case studies
  • Soft tissue tumors and treatment
  • Fungal Plant Pathogen Control
  • Management and Organizational Practices
  • Immunodeficiency and Autoimmune Disorders
  • Toxin Mechanisms and Immunotoxins
  • Polyomavirus and related diseases
  • Powdery Mildew Fungal Diseases
  • Gastrointestinal Tumor Research and Treatment
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Metastasis and carcinoma case studies

Keywords (DOAJ)

  • clinical oncology
  • cancer
  • targeted therapies

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: